Rocuronium
Rocuronium is a pharmaceutical drug with 127 clinical trials. Currently 4 active trials ongoing. Historical success rate of 99.0%.
Success Metrics
Based on 98 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
66
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.1%
98 of 103 finished
4.9%
5 ended early
4
trials recruiting
127
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery
Clinical Trials (127)
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery
Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies
Muscle Relaxation for Pediatric Adenotonsillectomy
Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients
Peribulbar Rocuronium in Adult Strabismus Surgery
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Ultrasound Guided Erector Spinae Block vs Thoracolumbar Interfascial Plane Block
Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine
Cognitive Functions After TIVA With Dexmedetomidine
Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg
Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery
QLB After Nephrectomy
Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients
Effect of Rocuronium on BIS Values
Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 127